Everolimus Represents an Advance in Immunosuppression for Patients Who Have Developed Cancer After Renal Transplantation

Abstract Renal transplantation provides the best quality of life for the patients with chronic end-stage renal failure. However, the immunosuppression necessary for graft survival may give rise to infectious complications, an increased risk of cardiovascular and neoplastic diseases, all of which can...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation proceedings 2009-07, Vol.41 (6), p.2332-2333
Hauptverfasser:	González, E, Andrés, A, Polanco, N, Hernández, A, Morales, E, Hernandez, E, Huerta, A, Ortuño, T, Gutiérrez Martínez, E, Praga, M, Morales, J.M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Creatinine - blood Cyclosporine - therapeutic use Everolimus Female Fundamental and applied biological sciences. Psychology Fundamental immunology Humans Immunosuppressive Agents - therapeutic use Kidney Transplantation - immunology Kidney Transplantation - mortality Male Medical sciences Middle Aged Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use Neoplasms - complications Neoplasms - pathology Pharmacology. Drug treatments Postoperative Complications Proteinuria Recurrence Retrospective Studies Sirolimus - analogs & derivatives Sirolimus - therapeutic use Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the urinary system Survival Rate Tacrolimus - therapeutic use Tissue, organ and graft immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!